摘要:
A power module includes a first bobbin, a primary winding coil, a circuit board assembly and a first magnetic core assembly. The primary winding coil is wound around the first bobbin. The circuit board assembly includes a printed circuit board, a second winding structure, at least one current-sensing element, a rectifier circuit and an electrical connector. The second winding structure has an output terminal. The current-sensing element includes a first conductor. The first conductor is a conductive sheet. A first end of the first conductor is in contact with the output terminal of the second winding structure. A second end of the first conductor is connected to the rectifier circuit. The primary winding coil is aligned with the second winding structure of the circuit board assembly and arranged within the first magnetic core assembly. The primary winding coil and the electrical connector are electrically connected with a system board.
摘要:
In one aspect of the present invention, a battery charging system has a first rectifier adapted for converting an AC voltage at an input thereof to a first DC voltage at an output thereof; a power factor correction (PFC) circuit coupled to the first rectifier, for correcting the power factor of the battery charging system and outputting a second DC voltage; a first power converter coupled to the PFC circuit, for converting the second DC voltage to a third DC voltage; a second power converter coupled to the first power converter, for converting the third DC voltage to a fourth DC voltage to be delivered to a battery; and a first controller adapted for sensing the fourth DC voltage at the output of the second power converter for regulating the second power converter to maintain the fourth DC voltage at a predetermined value.
摘要:
An information handling system includes a device, a controller, and a license manager subsystem. The controller is configured to determine whether the device has a license assigned and to extract a unique identification for the device in response to a request for information about the device. The license manager subsystem is configured to send the request for information about the device to the controller, to send the unique identification for the device to a license server as a request for the license for the device, to receive the license from the license server, and to assign the license to the device when the license is received.
摘要:
Determining matching degrees of information categories and displayed information is disclosed. In some embodiments, recorded user selection action information with respect to displayed information is analyzed to determine which pieces of displayed information have been selected and which pieces were displayed but not selected. In some embodiments, a matching degree for an information category is determined based on the recorded user selection information with respect to displayed information. In some embodiments, based on this matching degree determined for the information category, it is determined whether the information to be displayed for the information category is to be adjusted for a subsequent event in which information of the information category is to be displayed.
摘要:
In a method and system for controlling gain in an RF receiver, an RF signal is analyzed over different attack and decay windows, from which the receiver determines (1) if the signal is in an attack condition with dip values below a threshold level thus indicating a need for increasing signal gain, or (2) if the signal is in a decay condition with threshold values above a threshold level thus indicating a need for decreasing signal gain. The receiver applies attack and decay windows of different sizes and in an asynchronous manner to create a gain control scheme that is insensitive to transient effects such as channel interference and deep fading that affect the intensities of an in-band signal.
摘要:
The present invention comprises a new class of compounds capable of modulating Raf kinase and, accordingly, useful for treatment of Raf kinase mediated diseases, including melanomas, tumors and other cancer-related conditions. The compounds have a general Formula I wherein R1 is and A1, A2, A3, A4, X, Z, Z′, R1, R2, R3, R4, R5 and R6 are defined herein. The invention further comprises pharmaceutical compositions, methods for treatment of Raf kinase mediated diseases, and intermediates and processes useful for the preparation of compounds of the invention.
摘要:
A vision system is provided to determine a positional relationship between a photovoltaic device wafer on a platen and a printing element, such as a printing screen, on a remote side of the photovoltaic device wafer from the platen. A source emits ultraviolet light along a path that is transverse to a longitudinal axis of an aperture through the platen, and a diffuser panel is located along that path. A reflector directs the light from the diffuser panel toward the aperture. A video camera is located along the longitudinal axis of the aperture and produces an image using light received from the platen aperture, wherein some of that received light was reflected by the wafer. A band-pass filter is placed in front of the camera to block ambient light. The use of diffused ultraviolet light enhances contrast in the image between the wafer and the printing element.
摘要:
A method of identifying a reset condition includes the steps of determining if a stored value is equal to a specified value, executing a first mode if the stored value is not equal to the specified value, and executing a second mode if the stored value is equal to the specified value. The second mode also includes the step of setting the stored value to a value different than the specified value.
摘要:
The present teachings relate to compounds of Formula I: and pharmaceutically acceptable salts, hydrates, esters, and prodrugs thereof, wherein R1, R2, R3, Y, Z, and are as defined herein.The present teachings also provide methods of preparing compounds of Formula I and methods of using compounds of Formula I in treating, inhibiting, or preventing pathologic conditions or disorders mediated wholly or in part by deacetylases.